XML 74 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2014
Income Tax Disclosure [Abstract]  
Components of the Company's Deferred Income Tax Assets (Liabilities)

The significant components of the Company’s deferred income tax assets (liabilities) were as follows (in thousands):

 

     December 31,  
     2014      2013  

Deferred income tax assets:

     

Federal U.S. net operating loss carryforward

   $ 55,358       $ 36,561   

State net operating loss carryforward

     3,723         3,316   

Research and development credit, net

     7,177         3,786   

Orphan drug credit, net

     19,287         19,883   

Deferred rent

     4,069         5,132   

Deferred revenue

     3,989         8,217   

Depreciation

     1,337         1,438   

Other

     962         1,439   
  

 

 

    

 

 

 

Gross deferred income tax assets

  95,902      79,772   

Valuation allowance

  (94,297   (79,377
  

 

 

    

 

 

 

Net deferred income tax assets

  1,605      395   

Deferred income tax liabilities:

Prepaid expenditures

  (1,605   (395
  

 

 

    

 

 

 

Gross deferred income tax liabilities

  (1,605   (395

Net deferred income tax asset/(liability)

$ —      $ —     
  

 

 

    

 

 

 
Reconciliation of Reported Estimated Income Tax Benefit

The reconciliation of the reported estimated income tax benefit to the amount that would result by applying the U.S. federal statutory tax rate to the net income is as follows (in thousands):

 

     Year Ended December 31,  
     2014      2013      2012  

United States federal tax at statutory rate

   $ (13,410    $ (91    $ 2,927   

State taxes (net of federal benefit)

     (1,608      609         1,460   

Deferred income tax adjustments

     —           (855      (512

Deferred state blended rate adjustments

     3,034         (344      —     

Research credit, net

     (2,228      (226      —     

Transaction cost deduction

     (379      —           —     

Transaction cost deduction—prior year adjustment

     (564      —           —     

Orphan drug credit, net

     (139      (843      (4,896

Other permanent items

     (382      3         8   

Equity-based compensation

     756         241         279   

Fair value adjustment of preferred stock warrant liability

     —           219         (53

Change in valuation allowance

     14,920         1,287         787   
  

 

 

    

 

 

    

 

 

 

Income tax expense/(benefit)

$ —      $ —      $ —     
  

 

 

    

 

 

    

 

 

 
Reconciliation of the Beginning and Ending Amount of Gross Unrecognized Tax Benefits

A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows (in thousands):

 

     Year Ended December 31,  
     2014      2013      2012  

Beginning balance

   $ 1,708       $ 1,592       $ 1,534   

Increases/(decreases) for current year tax positions

     242         116         58   

Increases/(decreases) for prior year tax positions

     97         —           —     

Decreases as a result of expiration of statute of limitations

     —           —           —     
  

 

 

    

 

 

    

 

 

 

Ending balance

$ 2,047    $ 1,708    $ 1,592